-
Something wrong with this record ?
Senzitivita a specificita multimodálního a sonografického screeingu karcinomu ovaria a distribuce zachycených karcinomů podle stadií: Výsledky prevalenční screeningové studie UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) [Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)]
Usha Menon, Aleksandry Gentry-Maharaj, Rachel Hallett, Andy Ryan, Matthew Burnell, Aarti Sharma, Sara Lewis, Susan Davies, Susan Philpott, Alberto Lopes, Keith Godfrey, David Oram, Jonathan Herod, Karin Williamson, Mourad W. Seif, Ian Scott, Tim...
Language Czech Country Czech Republic
původní článek
v časopisu The Lancet Oncology
- MeSH
- CA-125 Antigen blood MeSH
- Middle Aged MeSH
- Humans MeSH
- Biomarkers, Tumor blood MeSH
- Ovarian Neoplasms * diagnostic imaging blood pathology MeSH
- Mass Screening MeSH
- Prevalence MeSH
- Aged MeSH
- Sensitivity and Specificity MeSH
- Ultrasonography methods MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Aged MeSH
- Female MeSH
Academic Unit of Abstetrics and Gynaecology (St Mary's Hospital Manchester Velká Británie
Barts and the London Londýn Velká Británie
Cancer Group Medical Research Council Clinical Trials Unit Londýn Velká Británie
Clinical Biochemistry University College London Hospital Londýn Velká Británie
Create Health Clinic Londýn Velká Británie
Department of Gynaecological Oncology (Belfast City Hospital Belfat Velká Británie
Department of Gynaecological Oncology Derby City Hospital Derby Velká Británie
Department of Gynaecological Oncology Liverpool Women's Hospital Liverpool Velká Británie
Department of Gynaecological Oncology Nottingham City Hospital Nottingham Velká Británie
Department of Gynaecological Oncology Portsmouth Velká Británie
Department of Gynaecological Oncology Royal Free Hospital Londýn Velká Británie
Department of Gynaecological Oncology St Michael's Hospital Bristol Velká Británie
Department of Gynaelogical Oncology James Cook University Hospital Middlesbrough Velká Británie
Department of Gynaelogical Oncology Llandudno Hospital North Wales Velká Británie
Department of Medicine Harvard Medical School Boston USA
Department of Social Policy London School of Economics Londýn Velká Británie
Northern Gynaecological Oncology Centre Queen Elizabeth Hospital Gateshead Velká Británie
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
Citace: The Lancet Oncology 2009; 10: 327-340
Bibliography, etc.Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19036634
- 003
- CZ-PrNML
- 005
- 20210308105808.0
- 007
- ta
- 008
- 191014s2009 xr d f 000 0|cze||
- 009
- AR
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a cze
- 044 __
- $a xr
- 100 1_
- $a Menon, Usha $u Gynaecological Oncology, University College London Elisabeth Garrett Anderson Institute for Women's Health, Londýn, Velká Británie
- 245 10
- $a Senzitivita a specificita multimodálního a sonografického screeingu karcinomu ovaria a distribuce zachycených karcinomů podle stadií: Výsledky prevalenční screeningové studie UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) / $c Usha Menon, Aleksandry Gentry-Maharaj, Rachel Hallett, Andy Ryan, Matthew Burnell, Aarti Sharma, Sara Lewis, Susan Davies, Susan Philpott, Alberto Lopes, Keith Godfrey, David Oram, Jonathan Herod, Karin Williamson, Mourad W. Seif, Ian Scott, Tim Mould, Robert Woolas, John Mudroch, Stephen Dobbs, Nazar N. Amso, Simon Leeson, Derek Cruickshank, Alistrair Mcguire, Stuart Campbell, Lesley Followfield, Naveena Shing, Anne Dawnay, Steven J. Skates, Mahesh Parmar, Ian Jacobs ; přeložila Táňa Glosová
- 246 31
- $a Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
- 500 __
- $a Citace: The Lancet Oncology 2009; 10: 327-340
- 504 __
- $a Literatura
- 650 12
- $a nádory vaječníků $x diagnostické zobrazování $x krev $x patologie $7 D010051
- 650 _2
- $a ultrasonografie $x metody $7 D014463
- 650 _2
- $a nádorové biomarkery $x krev $7 D014408
- 650 _2
- $a antigen CA-125 $x krev $7 D018394
- 650 _2
- $a senzitivita a specificita $7 D012680
- 650 _2
- $a plošný screening $7 D008403
- 650 _2
- $a prevalence $7 D015995
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a senioři $7 D000368
- 700 1_
- $a Gentry-Maharaj, Aleksandry $u Gynaecological Oncology, University College London Elisabeth Garrett Anderson Institute for Women's Health, Londýn, Velká Británie
- 700 1_
- $a Hallett, Rachel $u Gynaecological Oncology, University College London Elisabeth Garrett Anderson Institute for Women's Health, Londýn, Velká Británie
- 700 1_
- $a Ryan, Andy $u Gynaecological Oncology, University College London Elisabeth Garrett Anderson Institute for Women's Health, Londýn, Velká Británie
- 700 1_
- $a Burnell, Matthew $u Gynaecological Oncology, University College London Elisabeth Garrett Anderson Institute for Women's Health, Londýn, Velká Británie
- 700 1_
- $a Sharma, Aarti $u Gynaecological Oncology, University College London Elisabeth Garrett Anderson Institute for Women's Health, Londýn, Velká Británie
- 700 1_
- $a Lewis, Sara $u Gynaecological Oncology, University College London Elisabeth Garrett Anderson Institute for Women's Health, Londýn, Velká Británie
- 700 1_
- $a Davies, Susan $u Gynaecological Oncology, University College London Elisabeth Garrett Anderson Institute for Women's Health, Londýn, Velká Británie
- 700 1_
- $a Philpott, Susan $u Gynaecological Oncology, University College London Elisabeth Garrett Anderson Institute for Women's Health, Londýn, Velká Británie
- 700 1_
- $a Lopes, Alberto $u Northern Gynaecological Oncology Centre, Queen Elizabeth Hospital Gateshead, Velká Británie
- 700 1_
- $a Godfrey, Keith $u Northern Gynaecological Oncology Centre, Queen Elizabeth Hospital Gateshead, Velká Británie
- 700 1_
- $a Oram, David
- 700 1_
- $a Herod, Jonathan $u Department of Gynaecological Oncology, Liverpool Women's Hospital, Liverpool, Velká Británie
- 700 1_
- $a Williamson, Karin $u Department of Gynaecological Oncology, Nottingham City Hospital, Nottingham, Velká Británie
- 700 1_
- $a Seif, Mourad W. $u Academic Unit of Abstetrics and Gynaecology (St Mary's Hospital, Manchester, Velká Británie
- 700 1_
- $a Scott, Ian $u Department of Gynaecological Oncology, Derby City Hospital, Derby, Velká Británie
- 700 1_
- $a Mould, Tim $u Department of Gynaecological Oncology, Royal Free Hospital, Londýn, Velká Británie
- 700 1_
- $a Woolas, Robert $u Department of Gynaecological Oncology, Portsmouth, Velká Británie
- 700 1_
- $a Mudroch, John $u Department of Gynaecological Oncology, St Michael's Hospital, Bristol, Velká Británie
- 700 1_
- $a Dobbs, Stephen $u Department of Gynaecological Oncology (Belfast City Hospital, Belfat, Velká Británie
- 700 1_
- $a Amso, Nazar N. $u Department of Obstetrics and Gynaecology, Wales College of Medicine, Cardiff University, Cardiff, Velká Británie
- 700 1_
- $a Leeson, Simon $u Department of Gynaelogical Oncology, Llandudno Hospital, North Wales, Velká Británie
- 700 1_
- $a Cruickshank, Derek $u Department of Gynaelogical Oncology, James Cook University Hospital, Middlesbrough, Velká Británie
- 700 1_
- $a Mcguire, Alistrair $u Department of Social Policy, London School of Economics, Londýn, Velká Británie
- 700 1_
- $a Campbell, Stuart $u Create Health Clinic, Londýn, Velká Británie
- 700 1_
- $a Followfield, Lesley $u Cancer Research UK Sussex Psychosocial Oncology Group při Brighton & Sussex Medical School, University of Sussex, Falmer, Velká Britíánie
- 700 1_
- $a Shing, Naveena $u Barts and the London, Londýn, Velká Británie
- 700 1_
- $a Dawnay, Anne $u Clinical Biochemistry, University College London Hospital, Londýn, Velká Británie
- 700 1_
- $a Skates, Steven J. $u Department of Medicine, Harvard Medical School, Boston, USA
- 700 1_
- $a Parmar, Mahesh $u Cancer Group, Medical Research Council Clinical Trials Unit, Londýn, Velká Británie
- 700 1_
- $a Jacobs, Ian $u Gynaecological Oncology, University College London Elisabeth Garrett Anderson Institute for Women's Health, Londýn, Velká Británie
- 700 1_
- $a přeložila Táňa Glosová $4 trl
- 773 0_
- $t The lancet oncology CZ $x 1213-9432 $g Roč. 8, č. 2-3 (2009), s. 166-181 $w MED00012637
- 787 18
- $i Komentář: $a Cibula, David, $t Komentář $d 2009 $w bmc19036635
- 856 42
- $u http://dx.doi.org/10.1016/S1470-2045(08)70026-9 $y původní článek $z v časopisu The Lancet Oncology
- 910 __
- $a ABA008 $b B 2277 $c 1153 b $y p $z 0
- 990 __
- $a 20191010061949 $b ABA008
- 991 __
- $a 20210308105802 $b ABA008
- 999 __
- $a ok $b bmc $g 1454603 $s 1075200
- BAS __
- $a 3
- BMC __
- $a 2009 $b 8 $c 2-3 $d 166-181 $i 1213-9432 $m The lancet oncology CZ $x MED00012637
- LZP __
- $c NLK125 $d 20210308 $a NLK 2019-47/vt
